Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04020978 · ClinicalTrials.gov registry record · NA
Parametric PET of Genitourinary Cancer
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT04020978 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 11 participants.
The verdict
NCT04020978, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
Metastatic kidney cancer is usually treated with targeted therapy or immunotherapy which is costly and has low response rate. The current standard care is to perform anatomical imaging studies after a few cycles (months) of treatment to evaluate response. This approach exposes many patients to highly toxic, high expensive treatment without any benefit for months and delays initiation of other effective therapies. The goal of this study is to evaluate a parametric PET method that potentially identify response and assess drug efficacy with a few days to weeks of treatment.
Interventions
- DIAGNOSTIC_TEST Parametric PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-07-16 |
| Est. Completion | 2023-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04020978
The ClinicalTrials.gov registry entry for NCT04020978 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Parametric PET/CT is the first listed.
NCT04020978 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04020978 about?
NCT04020978 is a clinical study titled "Parametric PET of Genitourinary Cancer". Metastatic kidney cancer is usually treated with targeted therapy or immunotherapy which is costly and has low response rate. The current standard care is to perform anatomical imaging studies after a few cycles (months) of treatment to evaluate response. This approach exposes many patients to highl...
What is the current status of trial NCT04020978?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-07-16. Estimated completion is 2023-12-15.
What interventions are being tested in trial NCT04020978?
The interventions under investigation include: Parametric PET/CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04020978?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.